{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for monomethyl root_names_name in Any Name (approximate match)
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2018)
Source URL:
First approved in 2018
Source:
21 CFR 348
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2013)
Source URL:
First approved in 2007
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(2019)
Source:
BLA761137
(2019)
Source URL:
First approved in 2019
Source:
BLA761137
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2002)
Source:
BLA103964
(2002)
Source URL:
First approved in 2002
Source:
BLA103964
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2001)
Source:
BLA103949
(2001)
Source URL:
First approved in 2001
Source:
BLA103949
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1994)
Source:
BLA103411
(1994)
Source URL:
First approved in 1994
Source:
BLA103411
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ozuriftamab vedotin [INN]
Source URL:
Class:
PROTEIN
